Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: Results from the ACOSOG Z5031 trial

Matthew H.G. Katz, Nipun B. Merchant, Steven Brower, Megan Branda, Mitchell C. Posner, L. William Traverso, Ross A. Abrams, Vincent J. Picozzi, Peter W.T. Pisters

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: Results from the ACOSOG Z5031 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences